2. Academic Validation
  3. Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90

Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90

  • Cell Rep. 2019 Jan 29;26(5):1344-1356.e5. doi: 10.1016/j.celrep.2019.01.018.
Rebecca A Sager 1,  Mark R Woodford 1,  Sarah J Backe 1,  Alan M Makedon 2,  Alexander J Baker-Williams 1,  Bryanna T DiGregorio 2,  David R Loiselle 3,  Timothy A Haystead 3,  Natasha E Zachara 4,  Chrisostomos Prodromou 5,  Dimitra Bourboulia 1,  Laura S Schmidt 6,  W Marston Linehan 7,  Gennady Bratslavsky 1,  Mehdi Mollapour 8
Affiliations

Affiliations

  • 1 Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
  • 2 Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
  • 3 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
  • 4 Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • 5 Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK.
  • 6 Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • 7 Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • 8 Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY 13210, USA. Electronic address: [email protected].
PMID: 30699359 DOI: 10.1016/j.celrep.2019.01.018
Abstract

The molecular chaperone HSP90 stabilizes and activates client proteins. Co-chaperones and post-translational modifications tightly regulate HSP90 function and consequently lead to activation of clients. However, it is unclear whether this process occurs abruptly or gradually in the cellular context. We show that casein kinase-2 phosphorylation of the co-chaperone folliculin-interacting protein 1 (FNIP1) on priming serine-938 and subsequent relay phosphorylation on serine-939, 941, 946, and 948 promotes its gradual interaction with HSP90. This leads to incremental inhibition of HSP90 ATPase activity and gradual activation of both kinase and non-kinase clients. We further demonstrate that serine/threonine protein Phosphatase 5 (PP5) dephosphorylates FNIP1, allowing the addition of O-GlcNAc (O-linked N-acetylglucosamine) to the priming serine-938. This process antagonizes phosphorylation of FNIP1, preventing its interaction with HSP90, and consequently promotes FNIP1 lysine-1119 ubiquitination and proteasomal degradation. These findings provide a mechanism for gradual activation of the client proteins through intricate crosstalk of post-translational modifications of the co-chaperone FNIP1.

Keywords

BHD; Birt-Hogg-Dubé syndrome; FNIP1; Hsp90; O-GlcNAcylation; PP5; co-chaperone; folliculin-interacting protein 1; heat shock protein 90; serine/threonine protein phosphatase 5.

Figures